𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inflammatory bowel disease and cancer

✍ Scribed by B. Cola

Publisher
Springer
Year
1989
Tongue
English
Weight
587 KB
Volume
4
Category
Article
ISSN
0179-1958

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Nonmelanoma skin cancer in inflammatory
Nonmelanoma skin cancer in inflammatory bowel disease: A review
✍ Millie D. Long; Michael D. Kappelman; Clare A. Pipkin πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 2 views

At least 1 million new cases of nonmelanoma skin cancer (NMSC) are diagnosed in the United States each year and the incidence is increasing. A higher incidence of NMSC in organ transplant recipients on immunosuppression has been documented for some time, and recent studies indicate that patients wit

Chemoprophylaxis of colorectal cancer in
Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: Current concepts
✍ Jonathan S. Levine; Robert Burakoff πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 82 KB

Ulcerative colitis and Crohn's disease both confer an increased risk of developing colorectal cancer. The use of 5-aminosalicylate as a remission-inducing agent has been long accepted. Its use as a potential chemoprophylactic agent has been proposed and is used by some practitioners. This review exa

Two distinct groups of colorectal cancer
Two distinct groups of colorectal cancer in inflammatory bowel disease
✍ Stephan Brackmann; Solveig Norheim Andersen; Geir Aamodt; Borghild Roald; FrΓΈydi πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 192 KB

## Background: The histological variability in colitis-associated colorectal cancer (crc in inflammatory bowel disease [ibd]) and the association to clinical factors is unknown. ## Methods: In population-based material including 67 patients with crc in ibd, histopathology of the cancers and tissu